Evidence map›Paper›PMID 39951721›Full record

ArticleJournal of neurosurgery2025

Presenting cerebrovascular reactivity as a determinant of direct and indirect surgical revascularization success in North American patients with moyamoya vasculopathy.

Shuhei Shiino, Caleb Han, Maria Garza, Matthew Fusco, Rohan Chitale, L Taylor Davis, Wesley Richerson, Mark Rodeghier, Abigail R Dubois, Melanie Leguizamon and 3 more

Abstract read
In one paragraph

Article in Journal of neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shuhei ShiinoDepartments of1Neurology.
Caleb HanDepartments of1Neurology.
Maria GarzaDepartments of1Neurology.
Matthew Fusco3Neurosurgery.
Rohan Chitale3Neurosurgery.
L Taylor Davis2Radiology and Radiological Sciences.
Wesley RichersonDepartments of1Neurology.
Mark Rodeghier4Rodeghier Consulting, Chicago, Illinois; and.
Abigail R DuboisDepartments of1Neurology.
Melanie LeguizamonDepartments of1Neurology.
Kilian HettDepartments of1Neurology.
Lori C Jordan2Radiology and Radiological Sciences.
Manus J DonahueDepartments of1Neurology.

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Personalized hemodynamic and metabolic signatures of revascularization response in moyamoya diseaseR01NS133101 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Manus J Donahue, Lori Chaffin Jordan · 2024 to 2026
$1.7M
NICHD NIH HHS P50 HD103537NINDS NIH HHS R01 NS133101
6 · The paper itself

Abstract

objectiveBoth direct and indirect surgical revascularization techniques are commonly applied for the treatment of moyamoya disease and syndrome; however, responses can be heterogeneous and efficacy in the context of ischemic disease is not yet formally known from randomized clinical trials. Here, a prospective, longitudinal interventional study was performed to test the hypothesis that presenting 1) parenchymal cerebrovascular reactivity (CVR) and 2) CVR response times portend hemodynamic improvements after direct and indirect revascularization.

methodsCatheter angiography and hypercapnic blood oxygenation-weighted 3-T MRI (spatial resolution 3.5 × 3.5 × 3.5 mm, repetition time 2000 msec) were acquired before and 11.0 ± 7.9 months and 12.6 ± 6.9 months after surgery, respectively. In response to a 5% fixed-inspired CO2 respiratory challenge, time regression analyses were utilized to quantify maximal cerebrovascular reactivity (CVRmax) and time to reach maximal cerebrovascular reactivity (CVRdelay) to test the overarching hypothesis that presurgical measures predicted postsurgical CVRmax increases and CVRdelay reductions. Age, sex, surgical type, and preoperative impairment were considered as relevant explanatory variables in the regression analysis (significance criterion p < 0.05).

resultsA total of 47 operative hemispheres (32 indirect-only and 15 direct or combined direct-indirect revascularization) from 30 adult patients (median [range] age 43 [20-59] years) were evaluated. Direct/combined versus indirect revascularized brain hemispheres were matched for age (44.1 ± 11.1 vs 44.7 ± 13.8 years, p = 0.864), prior infarct (92.9% vs 92.6%, p = 0.976), and Suzuki stage within 1 stage on the 6-point staging scale (4.1 ± 0.7 vs 3.4 ± 0.6). Across all hemispheres and surgical procedures, CVRmax increased (p = 0.022) and CVRdelay decreased (p = 0.009) after surgery; however, responses varied considerably across hemispheres and surgical procedures. On multiple regression analysis, extent of preoperative impairment, quantified as preoperative CVRmax and moderated by the type of surgery performed, was an indicator of intervention-induced outcome in hemodynamics (p = 0.015). No effect of preoperative CVRdelay or age was found for outcomes.

conclusionsThe findings confirm heterogeneous CVR responses approximately 1 year after revascularization across patients, albeit moderated by type of revascularization. Of the variables considered, lower presurgical CVR provided the most significant indicator of the likelihood of postsurgical hemodynamic improvement.

Indexed as

Cerebral RevascularizationCerebrovascular CirculationMoyamoya DiseaseAdultFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNorth AmericaProspective StudiesTreatment OutcomeYoung Adultcerebrovascular reactivitydirect revascularizationEDASindirect revascularizationmoyamoyastrokevascular disorders

Identifiers

PMID39951721
PMCPMC12621042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.